Clinical Trial Update: HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label [Phase 2]

View source ↗

Summary

Phase II open-label trial update evaluating a dual HIV therapy with doravirine and raltegravir in HIV-1 infected patients; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• PIFELTRO (doravirine)

Snippet

Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | Conditions: HIV Infections | Phase 2 | Status: RECRUITING